Diabetic Foot clinical trials

Explore recruiting diabetic foot clinical trials.

Recruiting diabetic foot studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetic Foot trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NOVEL TREATMENT OF DIABETIC FOOT ULCER BY AUTOLOGOUS STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE: PHASE II OPEN-ENDED, MULTI-CENTRE STUDY (REGENDER)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Evaluation of the safety and efficacy of an advanced therapy medicinal product containing live ASCs in the treatment of diabetic foot syndrome – a double-blind, randomized study.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase-2, multi-centre, prospective, randomized, standard-of-care plus placebo-controlled, patient and central evaluator blinded, parallel arm, clinical study to evaluate safety, tolerability and efficacy of the recommended phase-2 dose of AUP1602-C in two dosing frequencies as a topical treatment for non-healing neuro-ischemic diabetic foot ulcers

Poland, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

NEurotrophins Mimetic compound for the treatment of diabetic foot UlcerS

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Healing Diabetic Foot Ulcers with Semaglutide

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Comparison of the efficacy of standard treatment associated with phage therapy versus standard treatment plus placebo for diabetic foot ulcers infected by Staphylococcus aureus

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Diabetic Foot trials by city

Diabetic Foot in Toronto Diabetic Foot in Vancouver Diabetic Foot in Montreal Diabetic Foot in Calgary Diabetic Foot in Edmonton Diabetic Foot in Ottawa Diabetic Foot in Winnipeg Diabetic Foot in Quebec City Diabetic Foot in Hamilton Diabetic Foot in Kitchener Diabetic Foot in London Diabetic Foot in Halifax Diabetic Foot in New York Diabetic Foot in Los Angeles Diabetic Foot in Chicago Diabetic Foot in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease